Skip to main content
Clinical Trials/CTRI/2022/08/045084
CTRI/2022/08/045084
Not yet recruiting
未知

HIP fracture Accelerated surgical TreaTment And Care tracK 2 Trial - HIP ATTACK-2

Population Health Research Institute0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Population Health Research Institute
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) age \=45 years;
  • 2\) diagnosis of hip fracture during working hours with a low\-energy mechanism requiring surgery;
  • 3\) troponin elevation on hospital arrival (at least one troponin level from hip fracture occurrence to randomization above the upper limit of normal); and
  • 4\) written informed consent.

Exclusion Criteria

  • 1\) taking a therapeutic dose of an anticoagulant for which no reversing agent is available;
  • 2\) patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
  • 3\) patients with peri\-prosthetic fracture, open fracture or bilateral fractures;
  • 4\) patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
  • 5\) patients with acute myocardial infarction with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or cardiogenic shock;
  • 6\) patients refusing consent; or
  • 7\) patients previously enrolled in HIP ATTACK\-2\.

Outcomes

Primary Outcomes

Not specified

Similar Trials